Pelvic Exenteration in India —
Radical cancer surgery,
a real chance at cure.
When recurrent or locally advanced pelvic cancer leaves no other option, pelvic exenteration offers a genuine path to cure. Medifly connects you with India's senior gynaecological oncologists at NABH & JCI-accredited hospitals — for anterior, posterior, or total exenteration, with full reconstructive support. From ₹3,00,000 all-inclusive.
Send your MRI/PET-CT reports via WhatsApp. A senior gynaecological oncologist confirms surgical candidacy, type of exenteration, and all-inclusive cost — in writing, within 24 hours.
What is Pelvic Exenteration?
Pelvic exenteration is a radical surgical procedure that removes some or all of the pelvic organs — including the uterus, cervix, vagina, bladder, and/or rectum — to achieve complete surgical clearance of a recurrent or locally advanced cancer that is confined to the pelvis. It is performed with curative — not palliative — intent.
When cancer recurs in the pelvis after initial treatment — surgery, radiation, or chemotherapy — it often infiltrates adjacent organs. Chemotherapy and radiotherapy may no longer be effective, particularly in a previously irradiated pelvis. In these situations, surgical removal of all involved tissue offers the only realistic chance of long-term survival or cure.
Pelvic exenteration is not undertaken lightly. It is one of the most complex operations in all of surgery — requiring a highly experienced multidisciplinary team, careful patient selection, and expert reconstructive planning. The right patient, operated on by the right surgeon, can achieve 5-year survival rates of 30–60%.
At Medifly's partner hospitals in Chennai, pelvic exenteration is performed by senior MCh-qualified gynaecological oncologists working alongside colorectal surgeons, urological oncologists, plastic reconstructive surgeons, and specialist stoma nurses — at a single institution, in a single operation, with multidisciplinary tumour board oversight.
What is Removed — by Type
The exact organs removed depend on the location and extent of the tumour. The goal is always R0 — achieving cancer-free margins around all resected tissue. Clear margins are the single strongest predictor of long-term survival.
What keeps pelvic exenteration patients awake — and how Medifly addresses each.
Whether you've been referred for this procedure by your oncologist, or you're researching it after a cancer recurrence — these are the real fears. Here is the truth, addressed honestly.
"Will I need a permanent stoma — a bag on my stomach — forever?"
This is the most common fear — and it deserves an honest answer. Whether you need a stoma depends entirely on the type of exenteration required. Anterior exenteration (bladder removed, rectum preserved) requires a urinary diversion — either a urostomy bag or a continent internal pouch (neobladder). Posterior exenteration (rectum removed, bladder preserved) requires a colostomy. Total exenteration typically requires both. However, continent urinary diversions — where urine is collected internally and you catheterise yourself — eliminate the need for a urine bag in many patients.
Every pelvic exenteration patient at Medifly's partner hospitals meets a specialist stoma nurse before surgery — for siting, education, and psychological preparation. Continent urinary diversion options are discussed for appropriate candidates.
"Is pelvic exenteration really the only option? How do I know?"
This is the right question to ask — and no surgeon should recommend exenteration without confirming it is truly the best option. The key questions are: (1) Is the cancer truly recurrent and confirmed by biopsy? (2) Is it confined to the pelvis — with no distant metastases on PET-CT? (3) Have other curative options (chemotherapy, re-irradiation, targeted therapy) been properly evaluated? Exenteration is only recommended when other options will not achieve cure. At Medifly's partner hospitals, a full multidisciplinary tumour board — gynaecological oncology, radiation oncology, colorectal surgery, urology, and radiology — reviews every case before the decision is confirmed.
Send us your full history — diagnosis, prior treatments, current imaging. A senior gynaecological oncologist reviews it within 24 hours and gives you an honest written assessment of whether exenteration is appropriate — or whether other options remain.
"The cost in my country is USD 80,000–1,20,000. I simply cannot afford it."
Pelvic exenteration in the USA costs USD 80,000–1,20,000 with hospital fees, surgical team fees, anaesthesia, and ICU care. In the UK privately, £50,000–£90,000. NHS waiting times for radical oncological surgery — where it is even offered — are 3–6 months. In India, the same operation by an equivalent or better-qualified gynaecological oncologist costs ₹3,00,000–₹8,00,000 (USD 3,600–9,600) all-inclusive. International patients often find that flights, accommodation, and surgery combined still cost less than the surgery alone at home.
Within 24 hours of receiving your reports, you receive a written, all-inclusive cost breakdown. No hidden fees. No surprise billing. You decide whether to proceed.
"I am coming from abroad. How do I manage a 14–21 day India stay for this major surgery?"
Pelvic exenteration requires a longer India stay than most procedures — typically 21–28 days in total (surgery plus hospital recovery plus post-discharge monitoring before flying). Managing this from abroad — visa, accommodation, daily support, language, and discharge — is genuinely complex. Medifly specialises in exactly this. We have coordinated patients from 20+ countries through major pelvic oncological surgery, including exenteration, from the first WhatsApp message to safe departure.
Medifly arranges: medical visa invitation letter · airport pickup · hospital admission · daily care coordinator contact · accommodation for 1–2 companions · discharge and pathology report coordination · follow-up plan with your home oncologist. You focus on recovery. We handle everything else.
"What will my quality of life be like after such major surgery?"
This is the most important question of all — and it deserves real data. Studies consistently show that the majority of appropriately selected patients who are cancer-free 1–2 years after pelvic exenteration report acceptable to good quality of life. The first 3–6 months are challenging — recovery from major surgery, adapting to stoma if present, pelvic floor physiotherapy, and psychological adjustment. After that, most patients return to independent living, work, and meaningful activities. Sexual rehabilitation — including neovaginal reconstruction in selected patients — is discussed and planned before surgery.
Medifly's partner hospitals have dedicated psycho-oncology support, stoma specialist nurses, pelvic rehabilitation physiotherapists, and reconstructive surgery options — all coordinated before and after the operation.
"How do I know the Indian surgeon is genuinely experienced in this ultra-complex operation?"
This matters more for pelvic exenteration than almost any other procedure. Surgical volume is directly linked to outcomes. Hospitals performing <5 exenterations per year have significantly higher complication rates than high-volume centres performing 20–40+ annually. Medifly only works with gynaecological oncologists who perform pelvic exenteration as part of their regular surgical practice — not as an occasional case. All are MCh/DNB Gynaecological Oncology trained, with fellowship training at leading institutions, and profiles available on request.
Every patient receives the assigned surgeon's full credential profile — including surgical volume data — before confirming the operation date. Transparency is non-negotiable.
Everything you need — in one coordinated pathway.
Pelvic exenteration is not a procedure you plan alone. Medifly manages every step — from surgical candidacy review to safe return home — so your entire focus can be on recovery and healing.
Senior Gynaecological Oncologists
Access to MCh/DNB Gynaecological Oncology specialists with 15–30 years of experience and dedicated pelvic exenteration volume at NABH & JCI-accredited hospitals in Chennai.
- High-volume exenteration centres
- Full multidisciplinary surgical team
- Surgeon credentials verified & shared
Multidisciplinary Tumour Board
Every pelvic exenteration case is reviewed by a tumour board — gynaecological oncology, colorectal surgery, urology, radiation oncology, and radiology — before the surgical plan is confirmed.
- PET-CT and MRI reviewed jointly
- Biopsy confirmation arranged
- Alternative options formally excluded
Reconstructive Surgery Planning
Reconstruction is planned before surgery. Options include neovaginal creation, continent urinary diversion (neobladder / Indiana pouch), and pelvic floor repair — all at the same operation where feasible.
- Plastic & reconstructive surgeon involved
- Continent urinary diversion options
- Neovaginal reconstruction available
End-to-End International Support
For patients from abroad — medical visa letter, airport pickup, hospital check-in, daily care coordinator, discharge planning, and coordination with your home oncologist. Designed for a 21–28 day India stay.
- 20+ countries served
- Companion accommodation arranged
- Discharge summary & digital records
Stoma & Psychological Support
Dedicated stoma nurse consultations before and after surgery. Psycho-oncology support throughout admission. Pelvic rehabilitation physiotherapy begins in hospital before discharge.
- Stoma siting & education pre-op
- Psycho-oncology support
- Pelvic physiotherapy started in-hospital
Transparent, All-Inclusive Pricing
One written quote covers surgical team, anaesthesia, ICU care, hospital stay (14–21 nights), pre-operative investigations, and post-operative review. 75–88% lower than USA, UK, or Singapore.
- Written quote within 24 hours
- No surprise billing — ever
- Insurance documentation support
What happens during pelvic exenteration — step by step.
Understanding the operation removes fear and helps you prepare. Here is exactly what occurs — from anaesthesia to closing — in a total pelvic exenteration, the most comprehensive form of the procedure.
Anaesthesia, Team Assembly & Positioning
General anaesthesia is administered with epidural for post-operative pain control. The patient is positioned in a modified lithotomy position. The entire surgical team assembles: gynaecological oncologist, colorectal surgeon, urological oncologist, and plastic reconstructive surgeon — all simultaneously present from the outset for complex cases.
Abdominal Exploration & Lymph Node Assessment
A midline laparotomy incision opens the abdomen. The peritoneal cavity is carefully explored to confirm no distant spread has been missed on imaging. Pelvic and para-aortic lymph nodes are sampled and sent for frozen section. If positive nodes indicate unresectable disease, the operation may be abandoned to spare the patient unnecessary surgery — this critical safety step is performed before any major organ removal.
En-Bloc Organ Resection
The affected pelvic organs are removed as a single unified specimen — en bloc — with wide surgical margins. For total exenteration: the uterus, cervix, vagina, bladder, and rectum are dissected free together, with the pelvic peritoneum and lymph nodes, and removed as one piece. The lateral pelvic walls are cleared. Frozen section analysis confirms clear margins before reconstruction begins.
Reconstruction & Diversion
Once clearance is confirmed, the reconstruction team creates urinary and bowel diversions and, where appropriate, pelvic floor reconstruction. Options include: ileal conduit (urostomy), continent Indiana pouch, or orthotopic neobladder for urinary diversion; end colostomy or coloanal anastomosis for the bowel; myocutaneous flap reconstruction (rectus abdominis or gracilis) to fill the pelvic dead space, reduce infection risk, and rebuild the pelvic floor. Neovaginal reconstruction is performed in suitable candidates.
Total operating time: 6–12 hours (total exenteration) · ICU stay: 1–3 nights · Hospital stay: 14–21 nights · Return to light activity: 6–8 weeks · Full recovery: 3–6 months · International departure: Day 21–28
Which type of pelvic exenteration is right for your case?
The type of exenteration depends entirely on the location of the tumour within the pelvis, which organs are involved, and what can be preserved without compromising the chance of clear surgical margins. Your tumour board makes this decision based on MRI, PET-CT, and examination under anaesthesia.
Total Pelvic Exenteration
Complete removal of all central pelvic organs: uterus, cervix, vagina, bladder, and rectum — along with surrounding pelvic peritoneum and lymph nodes. Performed when the tumour involves both the anterior and posterior compartments. Requires both urinary and bowel diversion. Offers the widest surgical margins and the best chance of cure in centrally located recurrences.
Widest clearance · Bladder + bowel diversionAnterior Pelvic Exenteration
Removes the uterus, cervix, vagina, and bladder — but preserves the rectum. Performed when the tumour is located anteriorly (towards the bladder) without posterior rectal involvement. Requires urinary diversion (urostomy or continent pouch). Bowel function is preserved completely. The preferred type when oncologically safe, as it avoids a colostomy.
Rectum preserved · Urinary diversion onlyPosterior Pelvic Exenteration
Removes the uterus, cervix, vagina, and rectum — but preserves the bladder. Performed when tumour involvement is posterior (rectovaginal or rectocervical). Requires a permanent colostomy or, in selected cases, a low colorectal anastomosis. Bladder function is maintained. Preferred when the tumour is posterior and the bladder is free of disease on imaging.
Bladder preserved · Bowel diversionExtended / Laterally Extended Exenteration
Extends the standard resection to include the pelvic sidewall musculature, obturator vessels, internal iliac vessels, or portions of bone (pubic ramus, sacrum) when tumour has invaded these structures. Significantly increases the technical complexity of the operation. Performed at select high-volume centres where appropriate surgical expertise and reconstructive teams are available.
Sidewall involvement · High-volume centres onlySupralevator vs. Infralevator Exenteration
The distinction between supralevator (above the levator ani muscle — preserves perineum) and infralevator (below, including the perineum and vulva) determines whether a perineal wound is created. Infralevator exenteration with perineal resection is required when the tumour extends to the lower vagina or vulva — and requires myocutaneous flap reconstruction of the perineal defect.
Perineal involvement · Flap reconstructionExenteration + Neovaginal Reconstruction
In premenopausal patients or those for whom sexual rehabilitation is a priority, neovaginal reconstruction — using a gracilis myocutaneous flap or sigmoid neovagina — can be performed at the same operation. This significantly improves post-operative sexual quality of life and psychological recovery. Discussed with every eligible patient during pre-operative counselling at Medifly's partner hospitals. See also: hysterectomy →
Sexual rehabilitation · Same operationPelvic exenteration is the right choice for these specific conditions.
Exenteration is a last-resort curative surgery — recommended when cancer is confined to the pelvis, has not spread to distant sites, and complete surgical clearance is achievable. Here are the most common indications.
Recurrent Cervical Cancer
The most common indication. When cervical cancer recurs centrally in the pelvis after radiotherapy, exenteration is often the only curative option available.
Recurrent Endometrial Cancer
Central pelvic recurrence of endometrial cancer after prior surgery and radiation — when the recurrence is contained and resectable.
Locally Advanced Rectal Cancer
Rectal cancers involving the uterus, vagina, or bladder — where complete en-bloc resection including gynaecological organs is required to achieve clear margins.
Vaginal Cancer
Primary vaginal cancers or locally recurrent vaginal cancers that involve the bladder or rectum and cannot be managed with radiotherapy alone.
Vulvar Cancer
Advanced or recurrent vulvar cancer with extension into the vagina, urethra, or anus — requiring infralevator exenteration with perineal resection.
Persistent Cervical Cancer (Post-CRT)
Cancer that has not responded to or persists after primary chemoradiation — confirmed on PET-CT and biopsy at 12 weeks post-treatment.
Bladder Cancer (Locally Advanced)
Bladder cancer involving adjacent gynaecological organs in women — where standard cystectomy alone would leave positive margins.
Sigmoid / Rectosigmoid Cancer
Colorectal cancers adherent to or directly invading the uterus, vagina, or bladder — where complete en-bloc resection requires a gynaecological oncologist.
The benefits of pelvic exenteration — and its honest risks.
Pelvic exenteration is major surgery with real risks — but for the right patient, it offers something no other treatment can: a genuine cure. Here is an unvarnished account of both sides.
Benefits
-
✓The only realistic chance of cure For pelvic-confined recurrent cancer, exenteration is often the only treatment with curative intent. In appropriately selected patients, 5-year survival rates of 30–60% are reported — outcomes that no other treatment can match.
-
✓Complete tumour clearance (R0 resection) The goal of en-bloc resection is negative surgical margins — the single most important factor predicting long-term survival. At high-volume centres, R0 resection rates exceed 80%.
-
✓Relief from tumour-related symptoms Recurrent pelvic cancer often causes severe pain, fistulae (abnormal connections between organs), bleeding, and urinary or bowel dysfunction. Exenteration resolves all of these — immediately and definitively.
-
✓Acceptable long-term quality of life Published quality-of-life data consistently shows that the majority of cancer-free survivors at 1–2 years report acceptable to good quality of life — returning to work, family life, and meaningful activities.
-
✓Reconstructive options minimise long-term impact Continent urinary diversions (no urine bag), low colorectal anastomosis (no stoma in selected cases), and neovaginal reconstruction significantly improve functional outcomes compared to older surgical techniques.
-
✓Psychological relief for cancer survivors Many patients describe the decision for exenteration as reclaiming agency over their cancer — accepting a major surgery in exchange for the possibility of being genuinely cancer-free. For many, this psychological benefit is profound.
Risks & Honest Limitations
-
!Major surgery — significant perioperative risk Pelvic exenteration carries a perioperative mortality of 1–3% at high-volume centres, and major complication rates of 30–50%. These include wound infection, pelvic abscess, anastomotic leak, urinary fistula, deep vein thrombosis, and prolonged ileus. Experienced centres mitigate this significantly.
-
!Permanent stoma in most cases Total exenteration requires both a urinary and a bowel diversion. Anterior exenteration requires urinary diversion. Posterior requires bowel diversion. While continent options reduce the bag requirement, most patients will have at least one permanent stoma to adapt to.
-
!Long, demanding recovery Full recovery takes 3–6 months. The first 6–8 weeks involve significant fatigue, wound management, stoma learning, and gradual return to activity. Nutritional support and physiotherapy are required throughout the recovery period.
-
!Surgery may not achieve clear margins In approximately 10–20% of cases, complete R0 resection cannot be achieved — either because imaging underestimated disease extent, or because frozen section reveals positive margins. In these cases, the surgeon may extend the resection or, rarely, close without complete clearance.
-
!Cancer recurrence remains possible Even after technically successful R0 exenteration, cancer recurs in 30–50% of patients. The majority of recurrences occur within the first 2 years and may present at distant sites. Close oncological surveillance for 5 years after surgery is essential.
Who is eligible for pelvic exenteration?
Patient selection is the most important determinant of outcome. Not every patient with pelvic cancer recurrence is a candidate — but for those who are, the potential benefit is transformative. Here is how eligibility is determined.
Ideal Candidates
Confirmed pelvic-confined recurrence on PET-CT (no distant metastases). Tumour resectable on MRI with achievable clear margins. Good performance status (ECOG 0–1). No prior extensive pelvic surgery that has obliterated anatomy. Adequate nutritional and psychological status. Prior treatments — surgery, radiotherapy, chemotherapy — have been exhausted or are not curative alone.
Borderline / Careful Selection Required
Involvement of pelvic sidewall (not an absolute contraindication if laterally extended exenteration is possible). Prior multiple abdominal surgeries creating dense adhesions. Moderate performance status (ECOG 2). Bilateral hydronephrosis or ureteric involvement. These cases are discussed at the tumour board — exenteration may still be possible with appropriate planning.
Contraindications to Exenteration
Distant metastases on PET-CT (liver, lung, peritoneum, bone). Tumour involving the pelvic sidewall or sciatic nerve without possibility of extended resection. Unfit for prolonged general anaesthesia. Ureteric obstruction above the pelvic brim suggesting high nodal disease. These are absolute contraindications — surgery would not be curative and would not be recommended.
Essential Pre-Operative Investigations
MRI pelvis (mandatory — to assess local extent and surgical margins). PET-CT whole body (to exclude distant metastases). Biopsy confirmation of recurrence (not imaging alone). Examination under anaesthesia (EUA) in selected cases. Full blood workup, cardiac assessment, nutritional screening, and anaesthetic review. Medifly arranges all investigations on arrival — nothing needs to be organised separately.
Molecular & Tumour Profiling
For patients with recurrent cervical or endometrial cancer, tumour molecular profiling (PD-L1, MMR status, HER2, BRCA) is performed to identify whether immunotherapy or targeted therapy should be combined with or used instead of surgery. The tumour board reviews this data before a final surgical recommendation is made.
Psychological Readiness Assessment
Pelvic exenteration is a life-altering procedure. All candidates undergo a psycho-oncology assessment before surgery. Patients who are not psychologically prepared — or who have not had adequate counselling about stoma, sexuality, and recovery — are supported to reach readiness before the operation is confirmed. This is not a barrier; it is a service.
From your first WhatsApp message to home — every step managed.
Whether you are in London, Lagos, or Lucknow — here is exactly how Medifly takes you from first contact to full recovery, in the fewest steps possible.
Send Your Reports
WhatsApp your MRI pelvis, PET-CT, biopsy report, and treatment history to +91 99449 38508. No referral needed. Takes 5 minutes.
Expert Assessment (24 hrs)
A senior gynaecological oncologist reviews your case with the tumour board. You receive a written assessment — candidacy, type of exenteration, reconstructive plan, and all-inclusive cost.
Arrival & Pre-op Workup
Medifly arranges airport pickup and hospital admission. Pre-operative investigations (bloodwork, cardiac review, nutritional assessment, stoma siting, anaesthetic clearance) are completed in 2–3 days before surgery.
Surgery, ICU & Recovery
Multidisciplinary surgical team operates. 6–12 hours operating time. 1–3 nights ICU. 14–21 nights total hospital stay. Daily care coordinator check-ins. Stoma nurse support from day one post-op.
Discharge & Safe Departure
Discharge summary, full pathology report, and digital records. Adjuvant treatment plan if required. International patients: fly home day 21–28. Medifly coordinates follow-up with your home oncologist via WhatsApp.
World-class radical oncological surgery — at a fraction of Western prices.
The same pelvic exenteration performed by an equivalent or better-qualified gynaecological oncologist costs 75–88% less in India than in the USA, UK, or Singapore. Here is a transparent, honest breakdown.
| Procedure | Cost in India |
|---|---|
| Anterior Pelvic Exenteration | ₹3,00,000 – ₹5,00,000 |
| Posterior Pelvic Exenteration | ₹3,00,000 – ₹5,00,000 |
| Total Pelvic Exenteration | ₹4,50,000 – ₹7,50,000 |
| Extended / Laterally Extended Exenteration | ₹6,00,000 – ₹10,00,000 |
| Exenteration + Neovaginal Reconstruction | ₹5,50,000 – ₹8,50,000 |
| Exenteration + Continent Urinary Diversion | ₹5,00,000 – ₹8,00,000 |
Important: The surgical quality, accreditation standards, and surgeon training at Medifly's partner hospitals are equivalent to leading oncological centres in the USA, UK, and Singapore. The cost difference reflects healthcare economics — not a difference in care quality.
What you need to bring — and what Medifly arranges.
Pelvic exenteration requires thorough pre-operative preparation. Here is exactly what patients need — and what Medifly's team organises on your behalf so nothing is left to chance.
The standards behind every Medifly surgical referral.
For a procedure as serious as pelvic exenteration, you need complete confidence in the team, the hospital, and the coordination. Here is what Medifly guarantees on every case.
NABH & JCI Accredited Hospitals
Every partner hospital holds National Accreditation Board for Hospitals (NABH) certification and Joint Commission International (JCI) accreditation — the same standards as leading hospitals in the USA and UK.
MCh Gynaecological Oncologists
All surgeons are MCh or DNB Gynaecological Oncology qualified — a 3-year post-MS superspecialty with fellowship training in radical pelvic surgery. Profiles verified and shared with every patient before surgery confirmation.
Multidisciplinary Tumour Boards
No pelvic exenteration is performed without a full tumour board review — gynaecological oncology, colorectal surgery, urology, radiation oncology, radiology, and pathology. The decision is never one surgeon's alone.
20+ Countries, 15,000+ Patients
Medifly has coordinated surgical care for patients from over 20 countries across Africa, Europe, the Middle East, South Asia, and North America — including patients for radical oncological procedures such as pelvic exenteration.
24-Hour Written Assessment
Send your reports on WhatsApp. Within 24 hours, a senior gynaecological oncologist gives you a written opinion on surgical candidacy, procedure type, expected outcomes, and all-inclusive cost. No fee. No obligation.
End-to-End Coordination
From medical visa letter to discharge summary to follow-up coordination with your home oncologist — Medifly manages every logistical element so you and your family focus entirely on healing.
Everything patients ask about pelvic exenteration in India.
The most important questions — answered honestly, by our clinical team, so you can make the best decision for your situation.
Pelvic exenteration in India costs approximately ₹3,00,000 to ₹8,00,000 (USD 3,600 to USD 9,600) depending on the type — anterior, posterior, or total — and whether reconstructive procedures such as neovagina creation or continent urinary diversion are included. This is 75–88% lower than equivalent surgery in the USA (USD 80,000–USD 1,20,000), UK private (£50,000–£90,000), or Singapore (USD 35,000–USD 80,000). The surgery is performed by MCh-qualified gynaecological oncologists with equivalent or better training at NABH and JCI-accredited hospitals. Send your reports to Medifly on WhatsApp (+91 99449 38508) and receive an all-inclusive written cost breakdown within 24 hours.
Pelvic exenteration is recommended for patients with pelvic-confined recurrent or persistent cancer — most commonly recurrent cervical cancer after radiotherapy, recurrent endometrial cancer, locally advanced rectal cancer involving pelvic organs, vaginal cancer, and selected vulvar cancers. The essential criteria are: (1) confirmed recurrence on biopsy, (2) no distant metastases on PET-CT, (3) tumour resectable with achievable clear margins on MRI, and (4) good general health to tolerate a major surgical procedure. A formal multidisciplinary tumour board review at Medifly's partner hospital confirms candidacy before any surgery is planned.
Pelvic exenteration is major surgery. Hospital stay is typically 14–21 days — including 1–3 nights in ICU post-operatively. Return to light indoor activity takes 6–8 weeks. Full recovery — including complete wound healing, stoma adaptation, and return to normal activities — takes 3–6 months. International patients should plan a total India stay of 21–28 days. Medifly's care coordinator stays with the patient throughout the inpatient recovery and coordinates follow-up with the home oncologist before departure.
Whether you need a stoma depends on the type of exenteration. Anterior exenteration (bladder removed, rectum preserved) requires urinary diversion — either a urostomy bag or a continent internal pouch (such as an Indiana pouch or neobladder) which eliminates the need for a bag. Posterior exenteration (rectum removed, bladder preserved) requires a colostomy, though low anastomosis may occasionally avoid a permanent stoma in selected cases. Total exenteration typically requires both a urinary and a bowel diversion. At Medifly's partner hospitals, continent diversions are offered to appropriate candidates — discussed and planned before surgery. A specialist stoma nurse provides full education and psychological preparation before and after the operation.
For carefully selected patients with recurrent cervical cancer confined to the pelvis, published 5-year survival rates after pelvic exenteration range from 30% to 60%, depending on margin status, lymph node involvement, and time to recurrence after primary treatment. Patients who achieve R0 (clear margin) resection have significantly better outcomes than those with positive margins. The most important prognostic factor is achieving clear surgical margins — at high-volume centres, R0 resection rates exceed 80%. Medifly's partner hospitals report outcomes consistent with leading international oncological centres. These figures are discussed honestly with every patient before surgery is planned.
International patients should plan a total India stay of 21–28 days. This includes: 2–3 days for pre-operative investigations and preparation; 14–21 days inpatient hospital recovery after surgery; and 3–5 days post-discharge monitoring and final clearance before flying. The majority of international patients fly home on day 24–28. Medifly arranges accommodation for the patient and up to 2 companions throughout the stay. A medical fitness-to-fly certificate is provided before departure. Medifly remains available by WhatsApp for clinical questions after the patient returns home.
Minimally invasive pelvic exenteration — using laparoscopic or robotic (da Vinci) approaches — is performed at select high-volume partner hospitals for carefully selected patients. Minimally invasive exenteration reduces blood loss, decreases wound complications, and may shorten hospital stay compared to open surgery. However, the approach depends on tumour size, prior surgery and radiation, and the need for reconstruction. The majority of pelvic exenterations are still performed via open laparotomy, particularly when reconstruction (flap, neovagina, continent diversion) is planned simultaneously. The tumour board determines the optimal approach for each individual case.
You should reach out to Medifly if any of these apply to you.
Pelvic exenteration is a time-sensitive decision. The earlier you reach out, the more options remain open. Here are the situations where a Medifly consultation is most urgent.
You Have Been Told You Need Pelvic Exenteration
If your oncologist has recommended pelvic exenteration — whether in your home country or elsewhere — Medifly can arrange a second-opinion tumour board review, confirm surgical candidacy, and provide a cost comparison with India within 24 hours. There is no obligation to proceed.
Cancer Has Recurred in the Pelvis After Prior Treatment
If you have had surgery, radiotherapy, or chemotherapy for a pelvic cancer — and imaging or biopsy now shows recurrence — contact Medifly immediately. The window for curative exenteration closes if the disease spreads beyond the pelvis. A 24-hour expert review helps determine whether you are still a surgical candidate.
The Cost in Your Country Is Unaffordable
If you are facing a USD 80,000–1,20,000 surgery bill in the USA, or a 6-month NHS waiting list in the UK — and time or cost is a barrier — the same surgery by an equivalent team in India costs ₹4,50,000–₹7,50,000. Medifly provides a written cost breakdown within 24 hours of receiving your reports.
Your Wait Time Is Dangerously Long
Recurrent pelvic cancer can progress rapidly. An 8-month NHS waiting list or a 6-month insurance authorisation delay is not medically safe. Medifly routinely arranges surgery within 1–2 weeks of the first WhatsApp message for candidates whose pre-operative workup is complete.
You Are a Tier-2 / Tier-3 Indian City Patient
If you are in a smaller Indian city without a gynaecological oncologist experienced in pelvic exenteration, Medifly arranges your complete pathway in Chennai — tumour board review, pre-operative workup, surgery, and follow-up — at Indian hospital rates, with full coordination.
You Want a Second Opinion Before Deciding
If you have been told exenteration is your only option and you are not sure — or if you have been told nothing more can be done and you want a second view — Medifly arranges a formal written second-opinion tumour board review. Many patients discover options they were not previously aware of.
The decision deserves the best information. A senior gynaecological oncologist reviews your reports within 24 hours and gives you a written, honest assessment — whether exenteration is appropriate, what type suits your case, what it will cost, and how soon we can arrange it. No fee. No obligation. Only clarity.
When pelvic exenteration is the answer, choose the team that gets it right.
Send your reports today via WhatsApp. Within 24 hours, a senior gynaecological oncologist tells you whether pelvic exenteration is appropriate, which type suits your case, exactly what it will cost, which Chennai hospital fits your needs, and how soon we can arrange it. Then — if you choose to proceed — we coordinate every detail from visa to surgery to lifelong follow-up. Explore: hysterectomy → · oophorectomy → · all gynaecology procedures →